רקומבינאט IU 1000

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

थमां उपलब्ध:

TEVA MEDICAL MARKETING LTD.

ए.टी.सी कोड:

B02BD02

फार्मास्यूटिकल फॉर्म:

POWDER FOR SOLUTION FOR INJECTION

प्रशासन का मार्ग:

I.V

द्वारा बनाया गया:

BAXTER S.A., BELGIUM

चिकित्सीय समूह:

COAGULATION FACTOR VIII

चिकित्सीय संकेत:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

प्राधिकरण की तारीख:

2010-07-01